Mission Possible

What Mission Possible does

Mission Possible is a Zurich-based early-stage venture capital firm founded in 2024 that invests in Swiss and Central/Eastern European technology spin-offs. The firm targets teams of 2–6 co-founders at co-founder, pre-seed, seed, and Series A stages writing tickets of CHF 200K–1M, with a target fund size of CHF 20–40M and a first close planned for 2025. Investment focus spans digital, health, deep tech, space, and impact sectors, with geographic allocation of 49–66% to Switzerland and the balance to Central/Eastern Europe. The founding partners — Nicolas Berg (deal sourcing, Switzerland) and Jeroen van den Oever (co-lead, life sciences) — together hold 40+ years of VC experience and have trained, judged, or coached more than 11,000 founders through venturelab, Startup Campus, and Venturekick over 24 years. Berg's track record includes cash.ch, XING, and co-founding Redalpine in 2007; van den Oever was a CFO/auditor at KPMG and co-founded DOPPL (now merged with Insphero).

The firm is partnered with five Swiss research institutions — ETH Zurich, University Hospital Zurich (USZ), EPFL, PSI, and EMPA — positioning itself as the closest VC to their spin-off pipelines. The team is expanded by Partner Adnan Kareem (Life Sciences, focus on neurosurgery/neuroscience), Partner & COO Ivy Zhao (ex-UBS Digital Investment Advisory, BCG, NAB), Researcher in Residence Aliya Bari (AI Ethics at University of Zurich), Entrepreneurs in Residence Tina Cai (Interdisciplinary Brain Science) and Srija Jogadhenu (Fintech), and Venture Partners Bea Knecht (Zattoo founder, ex-McKinsey), Natalia Novac (Delin Ventures, Eli Lilly, Merck), and Loris Mayr (Dealflow.eu, EIC Fund). The combined team covers 14 languages.

Mission Possible operates a community-led go-to-market model: deal sourcing is driven by the founding partners' coaching and judging footprint rather than outbound sales, with initial meetings booked via Calendly. The firm's revenue model is standard VC carried interest on portfolio exits, targeting a 30x return on pre-seed valuation within a 4–8 year holding period and double-digit returns within 7 years. The only publicly disclosed portfolio investment to date is Seprify, a CHF 3.5M seed round (2023) for plant-based cellulose ingredients replacing titanium dioxide in food and cosmetics. The firm is currently pre-fund-close and has not yet disclosed Limited Partner composition.

Name

Mission Possible

Legal name

Mission Possible

Website

https://missionpossible.vc

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Mission Possible is a Zurich-based early-stage venture capital firm founded in 2024 that invests CHF 200K–1M tickets in Swiss and Central/Eastern European tech spin-offs from digital, health, deep tech, space, and impact sectors, sourced through university partnerships with ETH, USZ, EPFL, PSI, and EMPA.

Ownership category

akta.pro rank

Product category

Venture Capital Services

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

Keywords

• Venture capital funding
• Early-stage investments
• Tech spin-offs
• Pre-seed capital
• Startup equity investment

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Portfolio Returns / Carried Interest: Generate returns through equity investments in portfolio companies. Returns realized through exits (acquisitions, IPOs). Target 30x on pre-seed valuation within 7 years. Typical VC carried interest structure on profits above the hurdle rate.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Mission Possible is a hands-on, super early-stage venture capital firm that invests CHF 200K-1M equity tickets in Swiss and Central/Eastern European tech spin-offs at co-founder, pre-seed, seed, and Series A stages. The fund targets a portfolio of 14-18 companies across digital, health, deep tech, space, and impact sectors, with a targeted fund size of CHF 20-40M (first close planned for 2025) and a 4-8 year holding period aimed at 30x returns on pre-seed valuations.

Differentiator

Problem solved

Functional benefit

Products and services

• Mission Possible Venture Capital Fund Super early-stage venture capital fund that invests CHF 200K-1M equity tickets in co-founder, pre-seed, seed, and Series A rounds across digital, health, deep tech, space, and impact sectors in Switzerland (49-66%) and Central/Eastern Europe. Targets a portfolio of 14-18 companies with a 4-8 year holding period and 30x return on pre-seed valuation.

Quantifiable outcome

• 40+ years combined VC experience among founding partners
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core.

• ETH ZurichcoreStrategic or Co-development PartnerStrong connection to ETH Zurich as a key university partner, supporting tech spin-offs from this leading Swiss technical university. The company describes itself as 'VC that is closest to teams from ETH'.
• University Hospital Zurich (USZ)coreStrategic or Co-development PartnerAffiliated with University Hospital Zurich for medical and health-related spin-off opportunities.
• EPFLcoreStrategic or Co-development PartnerConnected to EPFL as a partner institution for technology spin-offs, particularly in French-speaking regions of Switzerland.
• PSI (Paul Scherrer Institute)coreStrategic or Co-development PartnerPSI serves as a key research partner institution for deep tech and scientific spin-off opportunities.
• EMPA (Swiss Federal Laboratories for Materials Science and Technology)coreStrategic or Co-development PartnerPartner institution for materials science and technology spin-offs.
• venturelabcoreStrategic or Co-development PartnerFounding partners serve as trainers, coaches and jury members at venturelab. Organization that supports startup development in Switzerland with extensive founder network.
• Startup CampuscoreStrategic or Co-development PartnerFounding partners serve as trainers, coaches and jury members at Startup Campus. Startup development platform providing deal flow and ecosystem access.
• VenturekickcoreStrategic or Co-development PartnerFounding partners serve as trainers, coaches and jury members at Venturekick. Early-stage startup funding organization in Switzerland that provides both funding and coaching.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Redalpine: Swiss early-stage VC firm co-founded by Mission Possible's Nicolas Berg in 2007. Targets digital, health and deep tech across Europe with similar ticket sizes and pre-seed-to-Series A focus, making it the most direct comparable.
• Verve Ventures: Zurich-headquartered early-stage VC investing across Switzerland and Europe with a community-driven deal flow model. Comparable in geography, stage focus, and Swiss-rooted thesi.
• btov Partners: European early-stage VC with offices in Switzerland (St. Gallen) and Germany. Invests in digital and deep tech from pre-seed onward, comparable in stage and pan-European mandate.
• Venture Kick: Swiss pre-seed funding initiative where Mission Possible's founders serve as jury members. Provides early-stage capital to Swiss spin-offs and serves as a feeder for downstream VCs like Mission Possible.
• Speedinvest: Vienna-based early-stage VC covering CEE and Western Europe with sector-focused funds. Comparable in stage, geography (CEE angle) and multi-sector approach.
• Earlybird Venture Capital: European early-stage VC with deep tech and health sector funds. Comparable in stage, sector focus and European geographic mandate.

Broad incumbents

• Creandum: Pan-European early-stage VC with broader AUM and a more established brand. Comparable in pre-seed-to-Series A stage focus but operates at materially larger fund size.
• Index Ventures: Global VC with strong European roots and active investor in Swiss deep tech and health. Comparable in sector focus but at materially larger check sizes and later stages.

Regional players

• Session.vc: Swiss community-driven angel/VC platform focused on early-stage Swiss startups with co-investment model. Comparable in Swiss focus and community-led sourcing approach.

Others

• European Innovation Council (EIC) Fund: EU-backed deep tech and scale-up investor where Mission Possible venture partner Loris Mayr served as advisor. Comparable as a capital source for the same CEE/European deep tech targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/missionpossible-vc

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mission Possible